With pharmaceuticals playing such a big role in healthcare, innovation is a key focus for Novartis. But how are the high R&D costs paid for given that a lot of these disease-curing drugs are too expensive for the poor? We also discuss the controversial pharma clauses in the TPPA as well as the ethics of drug marketing.

See omnystudio.com/listener for privacy information.